EBV-positive mucocutaneous ulcer should be considered in the differential diagnosis of HIVassociated oral ulceration. Its unique clinical, histomorphological and immunophenotypic features should allow for its distinction in this setting, the diagnosis of which necessitates a conservative immune modulating therapeutic approach.
INTRODUCTION
Oral ulceration is a frequent clinical manifestation and complication of human immunodeficiency virus (HIV) infection with an estimated prevalence of 10 to 15% within this patient group. The incidence of oral ulceration increases in end stage disease (AIDSacquired immunodeficiency syndrome) and with decreased numbers of CD4 + T-cells. 1, 2 Oral ulceration may, however, be seen at any stage of HIV infection. The diagnosis of HIV/AIDS associated oral ulceration is complex due to the multitude of potential etiologies and known causes. Ulceration in these patients, irrespective of the cause, is more aggressive, painful and severely debilitating. These ulcers tend to have a protracted clinical course and are frequently refractory to therapy. 1, 3, 4 HIV/AIDS associated oral ulcers are predominantly infectious or neoplastic in origin. 1, 3, 4 Non-infectious, non-neoplastic forms of ulceration with unusual clinical presentations and where the etiopathogenesis is unknown, are grouped together as "ulceration not otherwise specified (NOS)". 5 This group of ulcers includes those with recurrent aphthous-type features.
The rapidly progressive opportunistic infectious process of necrotizing ulcerative stomatitis (NUS) shares many of the atypical clinical and non-specific histological features of the ulcers in this category. 1, 6 The range of polychemotherapy and multiple drug regimens to which HIV-positive patients are exposed for the treatment of HIV infection itself as well as the range of infectious and neoplastic diseases they suffer from, significantly increases the risk of potential drug interactions and cytotoxic tissue effects. This may result in iatrogenic ulceration. 7 Epstein-Barr virus-positive mucocutaneous ulcer (EBV MCU) is a recently documented entity that occurs in associated with various forms of immunosuppression. Lesions have been described in the oral cavity, gastrointestinal tract and skin [8] [9] [10] . They represent a unique, indolent form of EBV-driven B-cell lymphoproliferative disorder (LPD) which present as isolated, well-delineated ulcers that respond well to conservative therapeutic intervention.
The previously documented cases have occurred in patients on immunosuppressive medication and in the elderly with age-related immune senescence. 9, 11 EBV LPDs are known to occur in the setting of HIV/AIDS; however, their presentation and response to treatment are not well documented. LPDs in these patients most closely resemble the polymorphic lymphoid proliferations described in post-transplant patients. 12 , 13 EBV MCU to the best of our knowledge has not yet been described in immunosuppression due to HIV infection.
Confounding both the clinical and histopathological presentation of HIV-associated oral ulceration is the frequent occurrence of multiple co-existent pathologies in the same biopsy specimens. This is often characterized by multiple infectious processes occurring side by side with neoplastic or non-neoplastic disease. It is thus essential that clinicians obtain comprehensive clinical and medical histories in these patients and that chronic ulcers be biopsied in order to establish the most accurate diagnosis to facilitate appropriate management. 1, 4 We have recently encountered two cases of oral ulceration in HIV-positive patients, which have the clinical, histomorphological, and immunophenotypic features of EBV MCU. The aim of this study is to present this unusual form of oral ulceration in association with HIV infection for the first time.
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CASE PRESENTATIONS
Case one
A 54-year old HIV-positive male patient presented with a three-month history of an isolated area of painful ulceration involving the right soft palate. The area of ulceration extended to involve the tonsillar pillar and right maxillary retromolar area extending into the soft palate measuring 4cm in largest diameter ( Figure 1) . Furthermore, the patient had marked trismus 
MATERIALS AND METHODS
The histomorphological features noted in the two cases presented above were reviewed. The clinical details in each case were obtained from the histological request forms, patient records and through discussion with the clinicians in each case. The incisional biopsies were received in 10% neutral buffered formalin and stained by means of hematoxylin and eosin for routine light microscopic examination. The criteria for inclusion of the cases presented above were the presence of an isolated ulcerated lesion within the oral cavity in which an intense 7 polymorphous infiltrate within the superficial submucosa and lamina propria was identified.
The lesions had to have the clinical, morphological and immunophenotypic features which have been previously documented in the literature. 
Immunohistochemistry
Immunohistochemical staining (IHC) using mouse monoclonal antibodies to CD3, CD20, CD30, CD15, CD68 and Ki-67 was performed on both cases (Table 1) . Three micrometer formalin fixed paraffin embedded (FFPE) tissue sections were de-paraffinized and hydrated followed by heat induced epitope retrieval (HIER) with TRIS/EDTA buffer pH 9 for all above mentioned antibodies except CMV on which enzyme digestion was performed for 6 minutes at room temperature with a 0.05% pronase solution in Tris/HCl pH 7.2 buffer. After incubation with the primary antibody, positivity was detected by the Novocastra Novolink
Polymer Detection kit (Leica Biosystems, Newcastle Upon Tyne, UK) for ab's CD3, CD20
and Ki67 whilst antibodies CD30, CD15, CD68 and CMV were detected with Dako EnvisionTM + (Dako, Glostrup, Denmark) detection system. Positive and negative controls were used for verification of the staining in each case.
EBV in situ hybridization
Tissue sections three micrometer in thickness were cut from the FFPE tissue blocks and baked at 58ºC. EBV mRNA in-situ-hybridization was performed using proprietary reagents (Inform EBER DNP RNA probe, Roche Diagnostics, Mannheim Germany) on a Benchmark GX automated system (Ventana, Tucson, AZ) and visualized using the Ventana ISH/iView
Blue detection kit and Red counterstain according to the manufacturer's instructions. The INFORM EBER probe is a fluorescein-labelled oligonucleotide probe that detects early RNA transcripts EBER-1 and EBER-2. Positive and negative controls were used for verification of staining.
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RESULTS
Microscopic features
Histological examination of the hematoxylin and eosin stained tissue sections from both case one and two showed similar morphological features. Large areas of mucosal ulceration surfaced by a fibrinopurulent membrane were noted in both biopsy specimens. The adjacent hyperplastic stratified squamous epithelium showed features of inflammatory mediated cytological atypia. The ulcer bed comprised inflamed granulation tissue whilst a dense inflammatory infiltrate was present within the lamina propria and superficial submucosa in each case (Figure 3 ). The inflammatory infiltrate extended between minor salivary gland Large immunoblastic cells, each containing between 1-3 centrally located nuclei were scattered throughout. Some of the large atypical cells had a somewhat Reed-Sternberg-like (RS-like) morphology ( Figure 5 ). The neutrophils in both cases were largely restricted to the area in the vicinity of the ulcer bed whilst the few eosinophils noted were present throughout.
There was no evidence of granulomatous inflammation in any of the sections examined. immunoblastic and RS-like cells, the infiltrates did not appear to be overtly neoplastic largely due to their polymorphous nature.
Immunohistochemical profile
The polymorphous nature of the inflammatory infiltrates in both cases was confirmed by 
Fig. 8. A range of smaller lymphocytes, the intermediate cells with angulated nuclei as well as the immunoblastic and RS-like cells show immunoreactivity to CD30 as demonstrated in this micrograph (CD30, original magnification x200 -case two). A high-resolution version of this slide for use with the Virtual
Microscope is available as eSlide: VM00709. 
EBV in situ hybridization
EBER staining was detected in several of the smaller lymphocytes as well as in many of the larger B-cells including the immunoblastic and RS-like cells (Figures 10 & 11) . 
DISCUSSION
Oral mucosal ulceration is a frequent clinical feature of HIV infection, the presence and severity of which may be an indication of immune status and disease progression. 14 The diverse origin of ulcers in these patients is diagnostically challenging and may result in delayed therapeutic management. 1 The ability to distinguish between the varied etiologies both clinically and histopathologically is thus essential.
EBV MCU represents a form of LPD which arises in the setting of defective cellular immunity. Previously published cases of EBV MCU of the oral mucosa arose in patients receiving immune suppressive medication and in the elderly with age-related immune senescence. 8, 9 The oropharynx is the most frequently involved mucosal site and is unique due The B-cells show co-expression of CD30 in keeping with an activated phenotype. 15 In addition, many of these cells are immunopositive for CD15. True RS cells also co-express Although eosinophils are often recognized in EBV MCU, these are generally not as conspicuous. The infiltrate in TUGSE extends deep into the submucosa and contains numerous large atypical mononuclear cells which appear to be of T-cell phenotype. 15, 17 Early reports of this lesion indicated that some of these cells represented macrophages. 18 The large atypical cells have been shown to co-express CD30, a feature of both activated B-and T-cells.
Both TUGSE and EBV MCU are characterized by alarming clinical and histological features, although they are indolent self-limiting forms of oral ulceration which may show spontaneous regression with uneventful healing. The distinct histopathological and immunophenotypic features should allow for easy distinction of these entities. 9, 15 Whilst lymphomatoid granulomatosis may also enter the differential diagnosis of an EBV MCU in the setting of immunosuppression, these lesions primarily present with pulmonary 18 involvement. They are characterized by marked vasculitic changes and intraluminal thrombi in a T-cell rich background with scattered EBV-positive lymphoblastic cells. 19 The lack of lung involvement and vasculitic changes may allow for distinction from EBV MCU.
Necrotizing ulcerative stomatitis (NUS) is a rapidly progressive ulceronecrotic condition arising de novo or progressing from necrotizing ulcerative gingivitis and periodontitis. It represents an opportunistic anaerobic infectious process largely limited to the soft tissue but which may spread to involve the adjacent bone causing widespread necrosis and destruction. lesions. It is imperative that chronic non-healing ulcers in HIV/AIDS patients be biopsied in order for an accurate diagnosis to be rendered and for the most appropriate therapy to be instituted.
